An antithrombic compound
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Aspalatone

Item No. 13644

Technical Information
Formal Name
2-(acetyloxy)-2-methyl-4-oxo-4H-pyran-3-yl-benzoic acid ester
CAS Number
147249-33-0
Synonyms
  • Acetylsalicylic Acid Matol ester
Molecular Formula
C15H12O6
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 10 mg/mlDMSO: 10 mg/mlDMSO:PBS (pH 7.2) (1:10): 0.1 mg/mlEthanol: 1 mg/ml
λmax
237 nm
SMILES
O=C1C(OC(C2=C(OC(C)=O)C=CC=C2)=O)=C(C)OC=C1
InChi Code
InChI=1S/C15H12O6/c1-9-14(12(17)7-8-19-9)21-15(18)11-5-3-4-6-13(11)20-10(2)16/h3-8H,1-2H3
InChi Key
JVBIZYPCGNCWIT-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Aspalatone is an anti-platelet aggregator (IC50 = 180 µM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism.1 Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Han, B.H., Suh, D.Y., Yang, H.O., et alSynthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity. Arzneimittelforschung 44(10), 1122-1126 (1994).

    2. Kim, H.C., Choi, D.Y., Jhoo, W.K., et alAspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat. Life Sci. 61(24), 373-381 (1997).

    Product Citations

    Sonowal, H., Pal, P.B., Shukla, K., et alAspalatone prevents VEGF-induced lipid peroxidation, migration, tube formation, and dysfunction of human aortic endothelial cells. Oxidative Medicine and Cellular Longevity 2017, 2769347 (2017).